| Date & Time | 4 March 2026 12:00-13:00 CET |
|---|---|
| Address | Online |
Please save the date for Bridging Nordic ATMP, this season of ATMP Webinar Series hosted by the Nordic EATRIS Nodes (Sweden, Norway and Finland). The series will take place online, 12.00-13.00 CET, once a month with a lecture by an expert in the Advanced Therapy Medicinal Products (ATMPs) field. The next edition will feature the following speaker:
Bjarne Kuno Møller, MD, Dept. of Clinical Immunology, Aarhus University, will be speaking on Implementing a clinical core facility for gene and cellular therapy in the public health sector in Denmark.
Bjarne Kuno Møller is Medical Director, Head Consultant, and Associate Professor of Clinical Immunology at Aarhus University Hospital. As a leading figure in transplantation immunology and advanced cell therapies in Denmark, he heads the Blood, Cell and Tissue Center and directs the hospital’s Center for Gene and Cellular Therapy. His work spans cellular immunology, immune dysfunction, and regenerative therapies, supported by major national research grants. Dr. Møller has authored 140 scientific publications, supervised numerous PhD projects, and received the European Federation for Immunogenetics Medal of Honor in 2023.
Register for the webinar here.
Remember to save the dates and look out for updates on each webinar before the start of the event. The next webinar will take place on March 4th.
The previous events took place on:
- 5 February 2025 – Magnus Essand, Professor of Gene Therapy, Uppsala University, Chief Scientific Officer and co-founder, Elicera Therapeutics
- 12 March 2025 – David Morrow, EATRIS Senior Scientific Programme Manager
- 2 April 2025 – Seppo Ylä-Herttuala, Professor at the University of Eastern Finland
- 7 May 2025 – Kamal Mustafa, Professor at the University of Bergen
- 4 June 2025 – Marie Gårdmark, Co-founder of RegSmart Life Science AB and Anna Pasetto, Director of the Centre for Advanced Cell Therapy (ACT) at Oslo University Hospital
- 3 September 2025 – Janet Hoogstraate, Chief Executive Officer at NorthX Biologics
- 1 October 2025 – Joel Clinton Glover, Director of Norwegian Core Facility for Human Pluripotent Stem Cells at the University of Oslo and Oslo University Hospital.
- 3 November 2025 – Özcan Met, Associate Professor and Head of Cell Therapy Unit, at CCIT-DK and DTU HealthTech
- 3 December 2025 – Erja Kerkelä, Development Manager, Docent (Associate Professor) at the Advanced Cell Therapy Centre, Finnish Red Cross Blood Service.
- 4 February 2026 – Emanuela Oldoni, Scientific Lead Personalised Medicine at EATRIS
